![Thomas DiRaimondo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas DiRaimondo
Hoofd Techniek/Wetenschap/O&O bij
JANUX THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-07-2026
Profiel
Thomas DiRaimondo is the founder of Sitari Pharma, Inc., founded in 2013.
Dr. DiRaimondo currently holds the position of Chief Scientific Officer at Janux Therapeutics, Inc., starting in 2024.
Education history includes a doctorate from Stanford University and undergraduate and graduate degrees from the University of Michigan.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-02-2026 | 106.425 ( 0,18% ) | 2 M $ | 31-07-2026 |
Actieve functies van Thomas DiRaimondo
| Bedrijven | Functie | Begin |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2018 |
Eerdere bekende functies van Thomas DiRaimondo
| Bedrijven | Functie | Einde |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Oprichter | 01-08-2019 |
Opleiding van Thomas DiRaimondo
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
